SA
Log In
SIBN
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
9 analysts·Limited coverage
75
Score
9 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
9100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$23.00
+72.3%
Consensus
$25.50
+91.0%
Bull
$27.00
+102.2%
12-Month Target Range9 analysts
$23.00$25.50$27.00
Current $13.35Consensus
Current Price
$13.35
Upside to Consensus
$12.15

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+15.05%
EPS—
FY2028
Rev+15.39%
EPS—
FY2029
Rev+14.44%
EPS—

Earnings Surprises

Recent Analyst Actions

Feb 24, 2026Truist Financial
SI-Bone price target raised to $24 from $23 at Truist
Target:$24.00
+53.6%from $15.62
Dec 18, 2025Truist Financial
SI-Bone price target raised to $23 from $21 at Truist
Target:$23.00
+17.2%from $19.62
Dec 17, 2025Canaccord Genuity
SI-Bone price target raised to $27 from $26 at Canaccord
Target:$27.00
+39.0%from $19.42
Dec 16, 2025Needham
SI-BONE Inc. (SIBN) PT Raised to $27 at Needham, Added To Conviction List
Target:$27.00
+40.9%from $19.16
Dec 2, 2025Morgan Stanley
SI-Bone price target raised to $23 from $20 at Morgan Stanley
Target:$23.00
+21.9%from $18.87
Oct 15, 2025Truist Financial
SI-Bone price target lowered to $20 from $22 at Truist
Target:$20.00
+31.0%from $15.27
Aug 11, 2025Cantor Fitzgerald
Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
Target:$25.00
+59.4%from $15.68
Aug 6, 2024Truist Financial
SI-Bone price target lowered to $18 from $20 at Truist
Target:$18.00
+28.2%from $14.04
Aug 6, 2024Needham
SI-BONE Inc. (SIBN) PT Lowered to $19 at Needham
Target:$19.00
+32.3%from $14.36
Mar 28, 2024Piper Sandler
SI-Bone initiated with an Overweight at Piper Sandler
Target:$25.00
+58.0%from $15.82
Jul 12, 2023Needham
SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches
Target:$32.00
+18.8%from $26.93
Jan 6, 2023Morgan Stanley
Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18
Target:$18.00
+43.1%from $12.58
Dec 20, 2022Truist Financial
Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $17
Target:$17.00
+44.5%from $11.77
May 16, 2022Morgan Stanley
Morgan Stanly Says These 3 Stocks Could Surge Over 60% From Current Levels
Target:$22.00
+76.0%from $12.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance